TraceLink Reports Q1 2015 YoY Revenue Increase of 118% as Rapid Adoption of Life Sciences Cloud Continues
(firmenpresse) - NORTH READING, MA -- (Marketwired) -- 04/30/15 -- ., the world's largest track and trace network for connecting the Life Sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace, today announced YoY revenue growth of 118% for the first quarter of 2015. The company's strong revenue performance continues to be driven by global pharmaceutical companies choosing its platform to meet a broad range of regulatory track and trace deadlines in the , , , , , and the . New customer wins for the first quarter, which included large global pharmaceutical manufacturers, wholesale distributors, pharmacy chains and hospitals, have contributed to the company's two-year revenue compound annual growth rate (CAGR) of 103%, up 13% from Q4 2014.
"Our Q1 results demonstrate that the global transformation in Life Sciences is just starting to gain momentum," said Shabbir Dahod, president and CEO of TraceLink. "We're now seeing a shift in investment decisions as pharmaceutical companies turn their attention toward addressing the wide range of global serialization requirements that phase in over the next 18-24 months. Some of the big operational challenges they face include coordinating line upgrades with hundreds of contract manufacturers, processing massive amounts of serial number data associated with very large product volumes, and efficiently sharing compliance information with all of their supply chain partners -- as well as the government agencies that require it. The Life Sciences Cloud allows any pharma company to securely integrate and interoperate with all of its suppliers with just a single network connection, while at the same time, providing the processing elasticity to handle tens of billions of data transactions in a moment's notice. No other company offers a platform with these capabilities."
TraceLink achieved a range of other significant growth milestones in Q1 2015, including:
-- allowing manufacturers, distributors and dispensers to establish business relationships, exchange compliance information and share business processes;
-- to gear up TraceLink customers' production lines for serialization;
-- for pharmaceutical manufacturers that are already serializing products in global markets such as China, South Korea, Turkey, India, and the United States;
-- a 75% increase over Q4 2014; and,
-- to accommodate a 300% increase in staff over the past 15 months.
To learn more about meeting global pharmaceutical compliance deadlines designed to combat drug counterfeiting, and how to build a flexible global serialization, track and trace, and reporting platform for Brazil, China and other countries, visit .
TraceLink protects patients, enables health and ensures compliance for companies across the global Life Sciences supply network, including 15 of the top-20 global pharmaceutical companies. Leading businesses trust the TraceLink Life Sciences Cloud, our Amazon AWS-based cloud application platform, to deliver complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. Winner of numerous industry awards including the Amazon AWS Global Start-Up Challenge Grand Prize and the Edison Award for Innovation in Health Management, the TraceLink Life Sciences Cloud is used by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit or follow us on .
TraceLink is funded by , and .
Laura MacSweeney
Red Javelin Communications
(781) 395-6420
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 30.04.2015 - 13:00 Uhr
Sprache: Deutsch
News-ID 389826
Anzahl Zeichen: 0
contact information:
Town:
NORTH READING, MA
Kategorie:
Healthcare
Diese Pressemitteilung wurde bisher 234 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"TraceLink Reports Q1 2015 YoY Revenue Increase of 118% as Rapid Adoption of Life Sciences Cloud Continues"
steht unter der journalistisch-redaktionellen Verantwortung von
TraceLink Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
